Lamotrigine
Product Images NDC 53002-1512

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 53002-1512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60f518f2 5321 454d Aef0 49b3b3f8a36d 01

Chemical structure of Lamotrigine showing its chlorinated aromatic ring and triazine ring with amino groups, as depicted in the image.*

FDA Label Image

60f518f2 5321 454d Aef0 49b3b3f8a36d 02

A Kaplan-Meier failure probability curve showing comparison between Lamotrigine and Placebo over weeks. The vertical axis represents failure probability in percentage, and the horizontal axis represents time in weeks. The chart includes data censoring marks and distinguishes between Lamotrigine and Placebo treatment groups.*

FDA Label Image

60f518f2 5321 454d Aef0 49b3b3f8a36d 03

A line graph showing failure probability (%) on the y-axis and weeks on the x-axis. It compares two groups labeled Placebo and Lamotrigine over a period of approximately 75 weeks. Data points include censor marks, with Placebo showing a higher overall failure probability compared to Lamotrigine, which has a lower failure probability throughout most of the timeline.*

FDA Label Image

60f518f2 5321 454d Aef0 49b3b3f8a36d 04

This image shows a chart of Lamotrigine tablets in varying strengths and imprint codes. It includes light pink tablets with strengths of 25 mg (debossed with 'C148'), 100 mg (debossed with 'C149'), 150 mg (debossed with 'C151'), and 200 mg (debossed with 'C152').*

FDA Label Image

Label Image (Lbl530021512)

LAMOTRIGINE 100MG tablets packaging label by RPK Pharmaceuticals, Inc. The label indicates a 30-tablet bottle with directions to take a specified number of tablets daily as prescribed. It includes barcode, lot number, expiration date, and placeholder text for clinic name and patient information. The label states that lamotrigine is used to control seizures or bipolar disorder and advises cautious use.*

FDA Label Image

Label Image (Lbl530021513)

LAMOTRIGINE 25MG tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a carton containing 30 tablets with dosing instructions to take a specified number of tablets daily as directed by a prescriber. The label also includes barcode information and warnings about the drug's use for bipolar disorder. The label has spaces for patient, clinic, and prescription details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.